On Oct 24, major Wall Street analysts update their ratings for $IBM Corp (IBM.US)$, with price targets ranging from $150 to $260.
BofA Securities analyst Wamsi Mohan maintains with a buy rating, and maintains the target price at $250.
UBS analyst David Vogt maintains with a sell rating, and adjusts the target price from $145 to $150.
Jefferies analyst Brent Thill maintains with a hold rating, and maintains the target price at $245.
Evercore analyst Amit Daryanani maintains with a buy rating, and maintains the target price at $240.
BMO Capital analyst Keith Bachman maintains with a hold rating, and adjusts the target price from $210 to $260.
Furthermore, according to the comprehensive report, the opinions of $IBM Corp (IBM.US)$'s main analysts recently are as follows:
IBM's recent quarterly performance fell short of expectations with revenue and operating income not meeting the anticipated figures, influenced by underperformance in Consulting/Infrastructure sectors and higher workforce rebalance charges. Although the Software segment demonstrated notable growth, the prevailing share value near peak levels suggests that a more unblemished quarter was essential to maintain the recent positive trend.
IBM's recent financial outcomes have been a mixed bag, with a shortfall in revenues driven by underperformance in Consulting and Infrastructure segments. Despite this, the company's Software division continues to show robust growth, bolstered by recent acquisitions. Looking ahead to FY25, the inclusion of HashiCorp is seen as a promising avenue for growth. Nevertheless, there remains a cautious stance regarding IBM's capacity to expand its Software business, coupled with an anticipation of ongoing margin pressures.
Here are the latest investment ratings and price targets for $IBM Corp (IBM.US)$ from 7 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月24日，多家華爾街大行更新了$IBM Corp (IBM.US)$的評級，目標價介於150美元至260美元。
美銀證券分析師Wamsi Mohan維持買入評級，維持目標價250美元。
瑞士銀行分析師David Vogt維持賣出評級，並將目標價從145美元上調至150美元。
富瑞集團分析師Brent Thill維持持有評級，維持目標價245美元。
Evercore分析師Amit Daryanani維持買入評級，維持目標價240美元。
BMO資本市場分析師Keith Bachman維持持有評級，並將目標價從210美元上調至260美元。
此外，綜合報道，$IBM Corp (IBM.US)$近期主要分析師觀點如下：
IBM最近一個季度的表現不佳，營業收入和營運利潤未達預期，由於諮詢/製造行業表現不佳和人力資源重平衡費用增加所影響。儘管軟件部門展現出明顯增長，但目前股價接近峯值，表明更爲完美的季度對於維持最近的正面趨勢至關重要。
IBM最近的財務業績喜憂參半，營收不佳主要受到諮詢和製造行業表現不佳的影響。儘管如此，公司的軟件部門繼續表現強勁增長，得益於最近的收購。展望2025財年，HashiCorp的加入被視爲一個有前途的增長途徑。然而，對於IBM擴展其軟件業務的能力仍持謹慎態度，同時預計邊際壓力將持續存在。
以下爲今日7位分析師對$IBM Corp (IBM.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
